Toggle Main Menu Toggle Search

Open Access padlockePrints

Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group "Survey"

Lookup NU author(s): Simon Cotterill, Professor Andrew Pearson, Dr Jeanette Pritchard


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Background and Procedure. Most deaths from neuroblastoma occur within 2 years of diagnosis but there have been several anecdotal reports of relapse and death after much longer periods of follow up. In order to investigate and quantify the risk of late events we analysed data for patients registered with the European Neuroblastoma Study Group between 1982 and 1990. Out of a total of 1,277 children registered, 427 were alive with follow-up beyond 5 years from diagnosis (median follow-up of 8.8 years, range 5-14 years). Of these 406 were in remission with no prior recurrence, 16 were in remission having experienced a relapse prior to 5 years, and 5 were alive with progressive disease. Results. For the 406 patients in remission with no prior relapse the 10 year progression free survival (PFS) was 96% (CI 94-98). For those aged over 1 year with stage 4 disease at diagnosis 10 year PFS was 88% (CI 79-96) compared to 98% (CI 97-99) for other patients combined, P< 0.001. In a multivariate analysis of all 422 patients in remission at 5 years, significant risk factors for subsequent relapse were age > 1 yr with stage 4 disease at diagnosis (relative risk 10.5, P< 0.001) and prior relapse (RR 4.2, P= 0.01). Conclusions. The results of this study emphasise the importance of longterm follow-up of patients and the need for late monitoring of clinical trials in children with neuroblastoma. They also provide a baseline for comparison with future and hopefully more effective treatment programmes. Med. Pediatr. Oncol. 36:235-238, 2001. (C) 2001 Wiley-Liss, Inc.

Publication metadata

Author(s): Cotterill SJ, Pearson ADJ, Pritchard JA, Kohler JA, Foot ABM

Publication type: Article

Publication status: Published

Journal: Medical and Pediatric Oncology

Year: 2001

Volume: 36

Issue: 1

Pages: 235-238

ISSN (print): 0098-1532

ISSN (electronic): 1545-5017

Publisher: John Wiley & Sons, Inc.


DOI: 10.1002/1096-911X(20010101)36:1<235::AID-MPO1057>3.0.CO;2-N

Notes: Advances in Neuroblastoma Research: 1998 Conference


Altmetrics provided by Altmetric